InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

- Current share price for OCC : $0.680

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$185 Notice under Section 708(A) of the Corporations Act 18 Oct 2021 5:51PM $0.530 $0.680 risen by 28.30%
$185 Application for quotation of securities - OCC 18 Oct 2021 5:48PM $0.530 $0.680 risen by 28.30%
$185 Change of Director's Interest Notices 24 Sep 2021 9:53AM $0.480 $0.680 risen by 41.67%
$185 Letter to Shareholders - Annual General Meeting 21 Sep 2021 6:26PM $0.475 $0.680 risen by 43.16%
$185 Notice of Annual General Meeting/Proxy Form 21 Sep 2021 6:14PM $0.475 $0.680 risen by 43.16%
$185 Notice under Section 708(A) of the Corporations Act 16 Sep 2021 6:35PM $0.485 $0.680 risen by 40.21%
$185 Application for quotation of securities - OCC 16 Sep 2021 6:35PM $0.485 $0.680 risen by 40.21%
$185 Proposed issue of securities - OCC 16 Sep 2021 6:28PM $0.485 $0.680 risen by 40.21%
$185 Proposed issue of securities - OCC 16 Sep 2021 6:16PM $0.485 $0.680 risen by 40.21%
$185 Positive Data for CelGro Collagen Rope in ACL Reconstruction 15 Sep 2021 9:29AM $0.500 $0.680 risen by 36%
$185 OCC Secures Patents for Suture-Less Repair of Soft Tissue 7 Sep 2021 9:50AM $0.470 $0.680 risen by 44.68%
$185 Proactive Investors Interview with Orthocells MD 2 Sep 2021 2:34PM $0.460 $0.680 risen by 47.83%
$185 Ortho-ATI Shoulder Tendon Study Update Revised 31 Aug 2021 10:11AM $0.460 $0.680 risen by 47.83%
$185 Ortho-ATI Shoulder Tendon Study Update 31 Aug 2021 9:15AM $0.465 $0.680 risen by 46.24%
$185 Appendix 4E and Annual Report to Shareholders 27 Aug 2021 6:38PM $0.485 $0.680 risen by 40.21%
$185 Appendix 4G 27 Aug 2021 6:33PM $0.485 $0.680 risen by 40.21%
$185 Annual General Meeting 27 Aug 2021 6:30PM $0.485 $0.680 risen by 40.21%
$185 CelGro Nerve Study Results Presented at AOA annual Meeting 23 Aug 2021 9:26AM $0.480 $0.680 risen by 41.67%
$185 Notice under Section 708(A) of the Corporations Act 19 Aug 2021 5:26PM $0.490 $0.680 risen by 38.78%
$185 Application for quotation of securities - OCC 19 Aug 2021 5:24PM $0.490 $0.680 risen by 38.78%
$185 Notice under Section 708(A) of the Corporations Act 11 Aug 2021 4:54PM $0.530 $0.680 risen by 28.30%
$185 Application for quotation of securities - OCC 11 Aug 2021 4:53PM $0.530 $0.680 risen by 28.30%
$185 CelGro Facilitates Lymphatic Vessel Regeneration Updated 2 Aug 2021 1:51PM $0.550 $0.680 risen by 23.64%
$185 CelGro Facilitates Lymphatic Vessel Regeneration 2 Aug 2021 9:20AM $0.535 $0.680 risen by 27.10%
$185 Appendix 4C - Quarterly 28 Jul 2021 9:29AM $0.530 $0.680 risen by 28.30%

376 - 400 of 772 results

Page 16 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.